Literature DB >> 18632985

HDAC4 promotes growth of colon cancer cells via repression of p21.

Andrew J Wilson1, Do-Sun Byun, Shannon Nasser, Lucas B Murray, Kanyalakshmi Ayyanar, Diego Arango, Maria Figueroa, Ari Melnick, Gary D Kao, Leonard H Augenlicht, John M Mariadason.   

Abstract

The class II Histone deacetylase (HDAC), HDAC4, is expressed in a tissue-specific manner, and it represses differentiation of specific cell types. We demonstrate here that HDAC4 is expressed in the proliferative zone in small intestine and colon and that its expression is down-regulated during intestinal differentiation in vivo and in vitro. Subcellular localization studies demonstrated HDAC4 expression was predominantly nuclear in proliferating HCT116 cells and relocalized to the cytoplasm after cell cycle arrest. Down-regulating HDAC4 expression by small interfering RNA (siRNA) in HCT116 cells induced growth inhibition and apoptosis in vitro, reduced xenograft tumor growth, and increased p21 transcription. Conversely, overexpression of HDAC4 repressed p21 promoter activity. p21 was likely a direct target of HDAC4, because HDAC4 down-regulation increased p21 mRNA when protein synthesis was inhibited by cycloheximide. The importance of p21 repression in HDAC4-mediated growth promotion was demonstrated by the failure of HDAC4 down-regulation to induce growth arrest in HCT116 p21-null cells. HDAC4 down-regulation failed to induce p21 when Sp1 was functionally inhibited by mithramycin or siRNA-mediated down-regulation. HDAC4 expression overlapped with that of Sp1, and a physical interaction was demonstrated by coimmunoprecipitation. Chromatin immunoprecipitation (ChIP) and sequential ChIP analyses demonstrated Sp1-dependent binding of HDAC4 to the proximal p21 promoter, likely directed through the HDAC4-HDAC3-N-CoR/SMRT corepressor complex. Consistent with increased transcription, HDAC4 or SMRT down-regulation resulted in increased histone H3 acetylation at the proximal p21 promoter locus. These studies identify HDAC4 as a novel regulator of colon cell proliferation through repression of p21.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632985      PMCID: PMC2555950          DOI: 10.1091/mbc.e08-02-0139

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  64 in total

Review 1.  Histones and histone modifications.

Authors:  Craig L Peterson; Marc-André Laniel
Journal:  Curr Biol       Date:  2004-07-27       Impact factor: 10.834

2.  Intestinal epithelial cell surface membrane glycoprotein synthesis. II. Glycosyltransferases and endogenous acceptors of the undifferentiated cell surface membrane.

Authors:  M M Weiser
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

3.  Intestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation.

Authors:  M M Weiser
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

4.  Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model.

Authors:  J M Mariadason; D H Barkla; P R Gibson
Journal:  Am J Physiol       Date:  1997-04

5.  Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.

Authors:  Y Sowa; T Orita; S Minamikawa; K Nakano; T Mizuno; H Nomura; T Sakai
Journal:  Biochem Biophys Res Commun       Date:  1997-12-08       Impact factor: 3.575

6.  Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines.

Authors:  B G Heerdt; M A Houston; L H Augenlicht
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

7.  Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.

Authors:  A Lahm; C Paolini; M Pallaoro; M C Nardi; P Jones; P Neddermann; S Sambucini; M J Bottomley; P Lo Surdo; A Carfí; U Koch; R De Francesco; C Steinkühler; P Gallinari
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

8.  Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine.

Authors:  R P Ferraris; S A Villenas; J Diamond
Journal:  Am J Physiol       Date:  1992-06

9.  p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells.

Authors:  S Y Archer; S Meng; A Shei; R A Hodin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.

Authors:  Rick B Vega; Brooke C Harrison; Eric Meadows; Charles R Roberts; Philip J Papst; Eric N Olson; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more
  96 in total

1.  Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling.

Authors:  Sirichat Kaowinn; Seung Won Jun; Chang Seok Kim; Dong-Myeong Shin; Yoon-Hwae Hwang; Kyujung Kim; Bosung Shin; Chutima Kaewpiboon; Hyeon Hee Jeong; Sang Seok Koh; Oliver H Krämer; Randal N Johnston; Young-Hwa Chung
Journal:  Cell Oncol (Dordr)       Date:  2017-08-03       Impact factor: 6.730

2.  HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells.

Authors:  P Peixoto; V Castronovo; N Matheus; C Polese; O Peulen; A Gonzalez; M Boxus; E Verdin; M Thiry; F Dequiedt; D Mottet
Journal:  Cell Death Differ       Date:  2012-02-03       Impact factor: 15.828

3.  Intestinal epithelial-specific PTEN inactivation results in tumor formation.

Authors:  Do-Sun Byun; Naseem Ahmed; Shannon Nasser; Joongho Shin; Sheren Al-Obaidi; Sanjay Goel; Georgia A Corner; Andrew J Wilson; Dustin J Flanagan; David S Williams; Leonard H Augenlicht; Elizabeth Vincan; John M Mariadason
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

Review 4.  The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Authors:  N D Turner; L E Ritchie; R S Bresalier; R S Chapkin
Journal:  Curr Gastroenterol Rep       Date:  2013-09

5.  Nordihydroguaiaretic acid inhibits growth of cervical cancer SiHa cells by up-regulating p21.

Authors:  Peng Gao; Fei Zhai; Lei Guan; Jie Zheng
Journal:  Oncol Lett       Date:  2010-11-10       Impact factor: 2.967

6.  MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation.

Authors:  Eros Di Giorgio; Andrea Clocchiatti; Sara Piccinin; Andrea Sgorbissa; Giulia Viviani; Paolo Peruzzo; Salvatore Romeo; Sabrina Rossi; Angelo Paolo Dei Tos; Roberta Maestro; Claudio Brancolini
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

7.  Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.

Authors:  Sridurga Mithraprabhu; Anna Kalff; Annie Chow; Tiffany Khong; Andrew Spencer
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

8.  C-terminal binding protein and poly(ADP)ribose polymerase 1 contribute to repression of the p21(waf1/cip1) promoter.

Authors:  D L Madison; J R Lundblad
Journal:  Oncogene       Date:  2010-08-16       Impact factor: 9.867

9.  Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.

Authors:  B Song; Y Wang; Y Xi; K Kudo; S Bruheim; G I Botchkina; E Gavin; Y Wan; A Formentini; M Kornmann; O Fodstad; J Ju
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

10.  DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.

Authors:  Melissa J LaBonte; Peter M Wilson; William Fazzone; Susan Groshen; Heinz-Josef Lenz; Robert D Ladner
Journal:  BMC Med Genomics       Date:  2009-11-30       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.